HeartBeam, Inc.

HeartBeam, Inc.

BEAT·NASDAQ

$1.47

+8.1%
HealthcareMedical - Healthcare Information Services

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

At a Glance

Live Snapshot
Market Cap$50.63M
EPS-0.6200
P/E Ratio-3.85
Earnings Date05/07/2026

beat

Shares Outstanding

Last Annual Value

33.71M

3-Year CAGR

60%

5-Year CAGR

33%

10-Year CAGR

1%

HeartBeam, Inc.

HeartBeam, Inc. Competitors Analysis of shares-outstanding

BEAT · NASDAQ
Companyshares-outstanding
CAGR 3Y
CAGR 5Y
CAGR 10Y
BEAT logo
HeartBeam, Inc.
NASDAQ:BEAT
33.71M
18.4%34.0%1.0% 
91.88M
38.3%26.1%N/A
766.60K
15.3%4.8%N/A
3.16M
27.5%24.8%-17.1%
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
46.95M
27.1%26.5%N/A
40.69M
2.3%2.4%N/A
MNOV logo
MediciNova, Inc.
NASDAQ:MNOV
49.06M
0.0%0.2%4.0%
21.40M
41.4%-14.5%N/A
4.27M
7.5%5.0%N/A
46.81M
9.5%20.5%N/A
20.87M
1.3%-2.0%N/A
HeartBeam, Inc.

HeartBeam, Inc. Fair Value Envelope

BEAT · NASDAQ

Our analysis suggests that BEAT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.47, this represents a potential HIDDEN relative to our calculated worth for HeartBeam, Inc..

Intrinsic Value
Current Price: $1.47